| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,814 | 5,253 | 5,252 | 4,646 | | Cost of Revenue | 4,034 | 4,553 | 4,211 | 3,475 | | | Gross Profit | 780 | 700 | 1,041 | 1,171 | | | Operating Expenses | | Research Development | 94 | 117 | 123 | 499 | | Selling General and Administrative | 877 | 1,557 | 1,107 | 1,814 | | Non Recurring |
-
|
-
|
-
| 266 | | Others | 197 | 252 | 274 | 342 | | | | Total Operating Expenses |
-
|
-
|
-
| 2,921 | | | | Operating Income or Loss | (388) | (1,226) | (463) | (1,750) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 72 |
-
| 29 | (18) | | Earnings Before Interest And Taxes | (380) | (1,226) | (434) | (1,768) | | Interest Expense | (32) | 31 | 1 |
-
| | Income Before Tax | (348) | (1,257) | (435) | (1,768) | | Income Tax Expense | 19 | 4 | 6 | 1 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (367) | (1,261) | (441) | (1,769) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (367) | (1,261) | (441) | (1,769) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($367) | ($1,261) | ($441) | ($1,769) |
|
0.51% Nasdaq 0.00%
Income Statement
